79 results on '"Baracos, V"'
Search Results
2. Adherence to a combined exercise and dietary intervention in patients with gastrointestinal cancer undergoing neo-adjuvant therapy.
3. FIT: Functional and imaging testing for patients with metastatic cancer
4. SUN-PO112: Nutritional and Body Composition Changes During Radical Treatment for Locally Advanced Head and Neck Cancer (LA-HNC) Patients
5. A prospective study examining cachexia predictors in patients with incurable cancer
6. Dietary patterns and its relationship to sarcopenia in Portuguese patients with gastrointestinal cancer: An exploratory study
7. Ectopic fat in skeletal muscle and liver is associated with shorter survival in patients with colorectal liver metastases
8. Assessment of body composition and sarcopenia in patients with esophageal cancer: a systematic review and meta-analysis
9. ESPEN expert group recommendations for action against cancer-related malnutrition
10. A novel multimodal treatment strategy for cancer cachexia; rationale and motivation for the MENAC (Multimodal – Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial
11. MON-P109: Body Composition as a Predictor of Morbidity and Mortality in Surgical Patients with Bile Duct and Pancreatic Carcinoma
12. Role of body composition in early stage colorectal cancer (CRC) outcomes
13. Professor Kenneth Fearon: 3 August 1960–3 September 2016
14. MON-P085: Macronutrient Intake and Sarcopenia in Patients with Gastrointestinal Cancer
15. MON-P243: Skeletal Mass Index and Visceral Mass Index as Predictors of Length of Hospital Stay of Surgical Gastrointestinal Cancer Patients
16. MON-P047: Lower Skeletal Muscle Radiation Attenuation is Associated with Stricturing or Penetrating Phenotype in Patients with Crohn's Disease (CD): An Exploratory Study
17. Key determinants of energy expenditure in cancer and implications for clinical practice
18. Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia
19. EP-1261: Impact of sarcopenia on adverse effects in trimodality therapy for esophageal carcinoma
20. MON-LB011: Predictors of Sarcopenia in Patients With Gastrointestinal Cancer
21. Role of Factors Derived from Activated Macrophages in Regulation of Muscle Protein Turnover
22. The Regulation of Protein Breakdown by Prostaglandins
23. P265: L’apport oral de citrulline n’altère pas la réponse à la chimiothérapie (CPT-11/5-fluorouracile) dans une modèle expérimental de cancer colorectal
24. PP089-MON: Dietary Citrulline does not Alter Experimental Colon Cancer Response to CPT-11/5-Fluorouracil-Based Chemotherapy
25. Functional body composition and related aspects in research on obesity and cachexia: report on the 12th Stock Conference held on 6 and 7 September 2013 in Hamburg, Germany
26. Measurement of skeletal muscle radiation attenuation and basis of its biological variation
27. Low skeletal muscle is associated with toxicity in patients included in phase I trials
28. Body Composition is Linked to Toxicity and Outcome in Patients (PTS) Included in Phase I Trials
29. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery
30. Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma
31. The association of nutritional assessment criteria with health-related quality of life in patients with advanced colorectal carcinoma
32. O55 Impact des thérapies ciblées en cancérologie sur la masse musculaire et le tissu adipeux
33. O55 Impact des thérapies ciblées en cancérologie sur la masse musculaire et le tissu adipeux
34. 7158 POSTER Impact of Targeted Therapies on Muscle Loss and Adipose Tissue in Metastatic Renal Cell Carcinoma (mRCC)
35. Development and psychometric testing of the Adaptive Capacity Index, an instrument to measure adaptive capacity in individuals with advanced cancer
36. Muscle anabolism in advanced cancer: Is cachexia an immutable phenomenon?
37. Occurrence of sarcopenia in patients with non-small cell lung cancer (NSCLC) treated with erlotinib with normal or increased body mass index (BMI).
38. Sarcopenia in patients (pts) with hepatocelluar carcinoma (HCC).
39. Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer
40. 111 SARCOPENIA PREDICTS EARLY MORTALITY IN PATIENTS WITH CIRRHOSIS
41. Effect of everolimus therapy on skeletal muscle wasting in patients with metastatic renal cell carcinoma (mRCC): Results from a placebo-controlled study.
42. PP049-SUN LOSS OF FAT FREE MASS OCCURS DURING NEO-ADJUVANT CHEMOTHERAPY FOR UPPER Gl CANCER
43. Adaptive Capacity Index
44. PP062 ASSESSMENT OF MALNUTRITION AND NUTRITIONAL RISK: WHICH NUTRITIONAL CRITERIA PREDICT SURVIVAL IN ADVANCED MALIGNANT DISEASE?
45. Dénutrition en cancérologie: quand demander un avis spécialisé?
46. Prophylactic ciprofloxacin treatment prevented high mortality, and modified systemic and intestinal immune function in tumour-bearing rats receiving dose-intensive CPT-11 chemotherapy
47. Comment dépister la dénutrition au cours du cancer?
48. Markers of a chronic inflammatory state and trial completion: Data from cancer cachexia trial
49. La gestion de l’anorexie chez les patients ayant un cancer évolué : une revue critique de la littérature
50. The proteolysis-inducing factor: in search of its clinical relevance in patients with metastatic gastric/esophageal cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.